Simplex Trading’s Akoya BioSciences AKYA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-13,800
| Closed | -$19K | – | 8524 |
|
|
2025
Q1 | $19K | Sell |
13,800
-100
| -0.7% | -$219 | ﹤0.01% | 6600 |
|
|
2024
Q4 | $31K | Sell |
13,900
-200
| -1% | -$530 | ﹤0.01% | 6307 |
|
|
2024
Q3 | $38K | Buy |
14,100
+7,100
| +101% | +$17.3K | ﹤0.01% | 6117 |
|
|
2024
Q2 | $16K | Sell |
7,000
-100
| -1% | -$319 | ﹤0.01% | 7060 |
|
|
2024
Q1 | $33K | Buy |
7,100
+2,300
| +48% | +$11.9K | ﹤0.01% | 6656 |
|
|
2023
Q4 | $23K | Hold |
4,800
| – | – | ﹤0.01% | 6791 |
|
|
2023
Q3 | $22K | Sell |
4,800
-5,400
| -53% | -$31K | ﹤0.01% | 6525 |
|
|
2023
Q2 | $75K | Sell |
10,200
-6,100
| -37% | -$40.7K | ﹤0.01% | 5401 |
|
|
2023
Q1 | $133K | Buy |
16,300
+3,800
| +30% | +$39.7K | ﹤0.01% | 4820 |
|
|
2022
Q4 | $119K | Buy |
12,500
+2,200
| +21% | +$27.1K | ﹤0.01% | 4863 |
|
|
2022
Q3 | $121K | Buy |
10,300
+1,600
| +18% | +$21.1K | ﹤0.01% | 5249 |
|
|
2022
Q2 | $111K | Buy |
8,700
+7,500
| +625% | +$77.7K | ﹤0.01% | 5434 |
|
|
2022
Q1 | $13K | Buy |
+1,200
| New | +$13.9K | ﹤0.01% | 8643 |
|
Simplex Trading's AKYA Position: Q3 2023 in Review
Simplex Trading sold out of Akoya BioSciences (AKYA) in Q3 2023, closing a stake of 1,333 shares — an estimated $7.66K sold.
Simplex Trading first reported a position in AKYA in Q1 2022 and held it in 3 quarters. The position peaked at $17K in Q1 2022. 62 funds tracked by Wall St. Rank hold AKYA as of Q3 2023.
- Simplex Trading reported no remaining Akoya BioSciences position as of Q3 2023 after selling out during the quarter.
- Simplex Trading sold 1,333 Akoya BioSciences shares in Q3 2023, an estimated $7.66K.
- Simplex Trading first reported a position in Akoya BioSciences in Q1 2022 and held it in 3 quarters.
- Simplex Trading's Akoya BioSciences position peaked at $17K in Q1 2022.
- 62 funds tracked by Wall St. Rank held Akoya BioSciences as of Q3 2023.
Based on Simplex Trading's 13F filing for Q3 2023, filed 1 Nov 2023.